X
17Aug

An Update on Poison Pills, NOL Poison Pills and the COVID-19 Pandemic

Since the release of our recent article “Poison Pills, NOL Poison Pills and the COVID-19 Pandemic” in midApril, we continue to see a surge in the number of companies implementing poison pills (also referred to as shareholder rights plans), a type of defensive tactic used by a corporation’s board of directors against a hostile takeover bid. Please see full Publication below for more information....
By: Robinson & Cole LLP
Source Url: https://www.jdsupra.com/legalnews/an-update-on-poison-pills-nol-poison-25390/

Related

[Video] Why Culture Matters-Episode 3, the Role of the CCO in Culture

Welcome to this special five-part podcast series with Jay Rosen, VP of Business Development for Affi...

Read More >

M&A is top of mind: Will dealmakers actually double down in a downturn? The digital revolution could fuel “shadow protectionism”

Digital drives deals in every sector, ensuring tech is a primary focus of M&A across the board—even...

Read More >

Chinese Coronavirus Outbreak – What Employers Need to Know

Seyfarth Synopsis: First American case reported of deadly new Chinese coronavirus. The Centers for ...

Read More >

CFIUS Issues Proposed Regulations to Expand Jurisdiction to Real Estate Transactions

On September 24, 2019, the U.S. Treasury Department, as chair of the Committee on Foreign Investment...

Read More >

COVID Impact as a Standalone Indemnity in M&A Transactions

Introduction - The COVID virus has ushered in unprecedented and challenging times for our country a...

Read More >

DOL Issues Final Regulations for Salary Cutoff Amount for Overtime Exemption

The U.S. Department of Labor (DOL) on Sept. 24, 2019, issued its final overtime rule as it relates t...

Read More >